Sunfield Clinic is a medical institution that has submitted an approved regenerative medicine plan to the Ministry of Health, Labor and Welfare and obtained a Type 2 regenerative medicine provision plan number.
Medical institutions that provide regenerative medicine using stem cells create a regenerative medicine provision plan for each regenerative medicine technology to be implemented, and examine the safety, effectiveness, etc. by the specified certified regenerative medicine committee approved by the Ministry of Health, Labor and Welfare.
The clinic has structural equipment that allows counseling and various examinations in the hospital. In addition
to giving consideration to hygiene management and privacy as a medical institution, they strive to create an environment where patients can relax and receive counseling and medical treatment.
There are about 60 trillion cells in our body. Our tissues, such as the heart, brain, and skin, are made up of cells that play a very important role in our daily lives. It is divided into about 270 types of cells according to their role. The cells that give rise to these cells are “stem cells.” Stem cells are cells that transform into various cells and tissues and exist in fixed places in the body. It is a cell that produces cells to supplement the tissue when it is damaged.
It has long been known that these stem cells are present in the bone marrow. However, the number of stem cells that can be collected from the bone marrow is limited, and it was necessary to perform surgery that puts a burden on the patient, such as the need for general anesthesia. In 2000, Dr. Hedrick of UCLA (University of California, Los Angeles) discovered that abdominal subcutaneous fat contained a large amount of stem cells. Various studies have been conducted on the basic properties of adipose-derived mesenchymal stem cells. Adipose-derived mesenchymal stem cells, which are easy to collect, highly safe, and have a wide range of efficacy, are attracting attention as key cells in regenerative medicine.
In addition, the “Act on Ensuring the Safety of Regenerative Medicine (Act No. 85 of 2013)” was enforced on November 25, 2014, and clinical research (clinical research using human stem cells, etc.) is free. Rules to be respected by medical institutions and cell processed product manufacturers have been established so that research and development and practical application of high-quality regenerative medicine can be safely promoted under medical treatment, in order to provide regenerative medicine promptly and safely. The environment is getting ready.
At Sunfield Clinic, they received a regenerative medicine provision plan number from the Ministry of Health, Labor and Welfare, and received “autologous adipose-derived mesenchymal stem cell therapy for the purpose of preventing the progression of arteriosclerosis” (type 2 plan number PB3160006) and “chronic pain.
In a completely private treatment room that takes privacy into consideration, you can take a break after surgery and receive intravenous drip treatment. Loose reclining chairs and beds are installed.
Sunfield Clinic outsources cell culture to a “specified cell processed product manufacturer” that has obtained permission from the Ministry of Health, Labor and Welfare in accordance with the “Act on Ensuring Safety of Regenerative Medicine, etc.”
The adipose tissue collected from the patient is brought to a specific cell processed product manufacturing facility, which is a contractor, and after enzyme treatment, stem cells are separated from the fat and cultured and proliferated. Cell culture is carried out under strict control.
In addition, in order to ensure a high degree of safety, cell tests such as virus tests are performed when cells are stored. Furthermore, in order to prevent mistakes in sample collection, cells are cultivated under an operation control system that has introduced a strict quality control system such as history management of all processes.
- Languages : English, Japanese